[Form 4] Star Equity Holdings, Inc. Series A Cumulative Perpetual Preferred Stock Insider Trading Activity
Jennifer Palmer, a director of Star Equity Holdings, Inc. (STRR), reported dispositions of restricted stock units on 08/22/2025 related to the merger with Hudson Global, Inc. Palmer disposed of 1,570 Star common-stock RSUs, 1,723 additional Star common-stock RSUs, and two grants totaling 920 Star preferred-stock RSUs (two grants of 460 each). The filing states these RSUs were assumed by Hudson in the Merger and exchanged at settlement: Star common RSUs converted to 0.23 Hudson RSUs per Star RSU, while Star preferred RSUs converted to 1 Hudson RSU per Star RSU. The report shows 0 shares beneficially owned following the reported transactions for each listed grant. The Form 4 was filed by one reporting person and signed by an attorney-in-fact.
- None.
- None.
Insights
TL;DR: Director reported RSU dispositions tied to the Hudson merger; common RSUs converted at 0.23 ratio, preferred RSUs at 1:1, leaving zero Star holdings.
The Form 4 documents non-derivative disposals of restricted stock units by a director on the merger effective date, 08/22/2025. Material details include the conversion ratio for Star common-stock RSUs into Hudson RSUs (0.23:1) and a 1:1 conversion for Star 10% Series A preferred RSUs. The reported post-transaction beneficial ownership for each listed RSU grant is zero, indicating these specific Star RSUs were transferred or exchanged in full. This filing is procedural and tied directly to the merger, not an open-market sale.
TL;DR: Merger-related assumption and exchange of director RSUs documented; disclosures align with standard post-merger equity treatment.
The disclosure explains that Star restricted stock units were assumed by the acquirer and exchanged pursuant to the Agreement and Plan of Merger dated May 21, 2025. Grant dates and vesting schedules for each RSU cohort are specified: Nov 22, 2024; Mar 25, 2025; May 19, 2025; and Aug 18, 2025, with one-year vesting anniversaries noted. The Form 4 was executed by an attorney-in-fact, consistent with delegated signature practices. The filing contains no additional compensatory or cash consideration details.